Multiple myeloma. A study of forty patients. 1974

A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas

UI MeSH Term Description Entries
D008297 Male Males
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
December 1994, La Tunisie medicale,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
January 2015, Haematologica,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
June 2022, Journal of clinical medicine,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
January 2014, Annals of hematology,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
November 2017, BMC medical genetics,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
May 2019, Annals of medicine and surgery (2012),
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
May 1950, The American journal of the medical sciences,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
December 1973, The British journal of clinical practice,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
October 1990, Pathologie-biologie,
A I Pick, and J Schonfeld, and S Schreibman, and R Frohlichman, and J Pinkhas
September 1987, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!